L-dopa therapy in Parkinson's disease: a critical review of nine years' experience (Q35936567)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4903690 AND SRC:MED&resulttype=core&format=json

6 October 2019

review article

1 reference

title

L-dopa therapy in Parkinson's disease: a critical review of nine years' experience (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4903690 AND SRC:MED&resulttype=core&format=json

6 October 2019

1 reference

A. Barbeau

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:4903690

17 March 2023

language of work or name

English

0 references

publication date

1 December 1969

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4903690 AND SRC:MED&resulttype=core&format=json

full work available at URL

6 October 2019

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/4903690/?tool=EBI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:4903690

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/4903690/pdf/?tool=EBI

17 March 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:4903690

https://europepmc.org/articles/PMC1946468

17 March 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:4903690

https://europepmc.org/articles/PMC1946468?pdf=render

17 March 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:4903690

Canadian Medical Association Journal

17 March 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4903690 AND SRC:MED&resulttype=core&format=json

6 October 2019

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4903690 AND SRC:MED&resulttype=core&format=json

6 October 2019

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4903690 AND SRC:MED&resulttype=core&format=json

6 October 2019

page(s)

59-68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4903690 AND SRC:MED&resulttype=core&format=json

MODIFICATION BY DRUGS OF THE METABOLISM OF 3,4-DIHYDROXYPHENYLETHYLAMINE, NORADRENALINE AND 5-HYDROXYTRYPTAMINE IN THE BRAIN

6 October 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

EFFECT OF DRUGS ON METABOLISM OF CATECHOLAMINES IN THE BRAIN

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

DEMONSTRATION AND MAPPING OUT OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

The pathogenesis of Parkinson's disease: a new hypothesis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

Distribution of catechol compounds in human brain

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

REGIONAL DISTRIBUTION OF CIRCULATING BLOOD DURING SUBMERSION ASPHYXIA IN THE DUCK.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

THE METABOLISM OF ADRENALIN AND NORADRENALIN IN PATIENTS WITH BASAL GANGLIA DISEASE.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

The effect of a new decarboxylase inhibitor on endogenous monoamines

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

Localization of dopamine-beta-oxidase in brain

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

Occurrence and distribution of catechol amines in brain.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

Preliminary observations on abnormal catecholamine metabolism in basal ganglia diseases

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

Drug-induced extrapyramidal reactions. Treatment with diphenhydramine hydrochloride and dihydroxyphenylalanine.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

Excretion of dopamine in diseases of basal ganglia

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

Depression of norepinephrine and 5-hydroxytryptamine in the brain by benzoquinolizine derivatives

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

Intracellular distribution of catecholamines in the brain

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

Catechol compounds in rat tissues and in brains of different animals

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

The distribution of serotonin, 5-hydroxytryptophan decarboxylase, and monoamine oxidase in brain

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

Increase of Cerebral Catecholamines caused by 3,4-Dihydroxyphenylalanine after Inhibition of Peripheral Decarboxylase

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndrome

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

Excretion of Homovanillic and Vanilmandelic Acids Before and After Thalamotomy for Extrapyramidal Disorders

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

Changes in the metabolism of 3,4-dihydroxyphenylethylamine (dopamine) in the striatum of the mouse induced by drugs

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

Urinary amines in patients undergoing thalamotomy for Parkinson's disease

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

Possible role of brain dopamine

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

Dopamine and basal ganglia disorders

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

The release of dopamine from the putamen

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

Effects of L-DOPA on pharmacological parkinsonism

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

Homovanillic acid in the cerebrospinal fluid: studies in Parkinson's syndrome and other diseases of the CNS

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

L-dopa in postencephalitic parkinsonism.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

Modification of Parkinsonism--chronic treatment with L-dopa

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1946468

L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism

24 September 2018

1 reference

12 December 2020

Reversal of the reserpine-induced suppression of the conditioned avoidance response in the cat by L-DOPA

1 reference

12 December 2020

Biochemistry of Parkinson's disease.

1 reference

12 December 2020

On the treatment of Parkinson's syndrome with monoamine oxidase inhibitors alone and in combination with L-dopa

1 reference

12 December 2020

Amantadine in the Treatment of Parkinson's Disease

1 reference

12 December 2020

Biochemical and pressor effects of oral D,L-dihydroxy-phenylalanine in patients pretreated with antidepressant drugs

1 reference

12 December 2020

Effect of L-DOPA on depression

1 reference

12 December 2020

L-dopa for progressive suparanulcear palsy.

1 reference

12 December 2020

Treatment of Parkinson's disease by L-DOPA

1 reference

12 December 2020

L-DOPA therapy of parkinsonism

1 reference

12 December 2020

Recent advances in the treatment of parkinsonism.

1 reference

12 December 2020

[The L-dihydroxyphenylalanine (L-DOPA) effect in Parkinson's syndrome in man: On the pathogenesis and treatment of Parkinson akinesis]

1 reference

12 December 2020

Renin-Aldosterone System in Parkinson's Disease

1 reference

12 December 2020

Method of measurement of akinesia

1 reference

12 December 2020

[Further experimental studies on the catecholamine metabolism in extrapyramidal diseases (Parkinson and chorea syndromes)].

1 reference

12 December 2020

Dopamine and the central nervous system

1 reference

12 December 2020

Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)

1 reference

12 December 2020

Parkinsonism and DOPA

1 reference

12 December 2020

URINARY EXCRETION OF A 3-4, DIMETHOXYPHENYLETHYLAMINE-LIKE SUBSTANCE IN PARKINSON'S DISEASE

1 reference

12 December 2020

Effect of phenothiazines on dopamine metabolism and biochemistry of Parkinson's disease

1 reference

12 December 2020

ON THE CONTROL OF AKINESIA AND OTHER EXTRAPYRAMIDAL MOTOR DISORDERS WITH L-DOPA (L-DIHYDROXYPHENYLALANINE)

1 reference

12 December 2020

THE ACTION OF L-DIHYDROXYPHENYLALANINE IN PATIENTS RECEIVING NICALAMIDE

1 reference

12 December 2020

1 reference

12 December 2020

Effects of L-dopa in Parkinson's disease.

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4903690 AND SRC:MED&resulttype=core&format=json

6 October 2019

1 reference